Commitments and Contingencies - Additional Information (Details)			1 Months Ended		12 Months Ended
	Sep. 22, 2022 purportedStockholder	Aug. 01, 2018 USD ($)	Nov. 30, 2019 USD ($)	Oct. 31, 2017 USD ($) shares	Dec. 31, 2018 USD ($)	Sep. 30, 2022 USD ($)	Mar. 31, 2022 USD ($)
Loss Contingencies [Line Items]
Asset acquisition, contingent consideration, liability						$ 0
Number of purported stockholders | purportedStockholder	3
Collaborative Arrangement
Loss Contingencies [Line Items]
Amount paid upon execution of collaboration agreement		$ 6,000,000			$ 3,000,000
Collaborative arrangement, amount of collaborative agreement to be paid		9,000,000
Contingent payments due upon achievement of certain development and regulatory milestones		$ 75,000,000
Avizorex
Loss Contingencies [Line Items]
Contractual regulatory milestone payment							$ 8,000,000
Avizorex
Loss Contingencies [Line Items]
Asset acquisition, consideration transferred			$ 10,200,000
Milestone payments			$ 69,000,000
Envisia
Loss Contingencies [Line Items]
Milestone payments				$ 45,000,000
Payments to acquire productive assets				$ 10,500,000
Number of shares issued in transaction (in shares) | shares				263,146
Sale of stock, consideration received on transaction				$ 14,300,000
Loss contingency, milestone period				15 years